The U.S. Drug Administration approves the provision of Pfizer's new crown vaccine to children aged 5 to 11 years old

　　China News Service, Washington, October 29 (Reporter Sha Hanting) The U.S. Food and Drug Administration (FDA) approved the provision of Pfizer's new crown vaccine to children aged 5 to 11 under emergency authorization on the 29th local time.

　　FDA Acting Commissioner Janet Woodcock issued a statement on the same day, saying that children of this age who are allowed to receive the new crown vaccine will enable "we go one step further towards normalcy."

He also said that the FDA has made a "perfect and sufficient assessment" of the data submitted by Pfizer, confirming the safety and effectiveness of the vaccine, so parents can believe that the vaccine meets strict standards.

On September 13, local time, a public school in New York City opened. Students in front of a public school in Queens lined up to enter the school.

Photo by China News Agency reporter Liao Pan

　　This time Pfizer will provide two doses of the new crown vaccine to children aged 5 to 11 years old, the dose is one-third of adults.

Pfizer said that studies have shown that the dose is sufficient for vaccine protection and hopes to reduce side effects.

　　Pfizer's study of 2,268 children showed that the vaccine is 91% effective in preventing symptomatic new crown infections.

　　According to the United States Centers for Disease Control and Prevention (CDC) statistics, among the 5- to 11-year-old age group, 8,300 people have been hospitalized due to new coronary pneumonia, of which about one-third are in the intensive care unit, and the death toll is close to 100.

　　At the FDA expert committee meeting held on the 26th, many experts said that although they support the provision of new crown vaccines to children of this age, they oppose the mandatory vaccination of this group.

Some experts believe that only children 5 to 11 years old who are at high risk should be vaccinated against the new crown.

　　Next, the CDC will evaluate the provision of Pfizer's new crown vaccine to children between 5 and 11 years of age, and give recommendations on which people in this age group should be vaccinated.

　　Currently, there are approximately 28 million children between the ages of 5 and 11 in the United States.

According to the Kaiser Family Foundation (Kaiser Family Foundation) survey, only 27% of parents of children of this age currently express their willingness to vaccinate their children as soon as the new crown vaccine for this age is approved.

(over)